Expert Opinion on Biological Therapy
Academic journal
| Discipline | Therapeutics |
|---|---|
| Language | English |
| Edited by | Michael Morse |
| Publication details | |
| History | 2001-present |
| Publisher | Taylor & Francis |
| Frequency | Monthly |
Impact factor | 3.974 (2017) |
| Standard abbreviations ISO 4 (alt) · Bluebook (alt1 · alt2) NLM (alt) · MathSciNet (alt  ) | |
| ISO 4 | Expert Opin. Biol. Ther. |
| Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus | |
| ISSN | 1471-2598 (print) 1744-7682 (web) |
| LCCN | 2001243388 |
| OCLC no. | 48476209 |
| Links | |
| |
Expert Opinion on Biological Therapy is a monthly peer-reviewed medical journal covering research on all aspects of biological therapy, including gene therapy and gene transfer technologies, therapeutic peptides and proteins, vaccines and antibodies, and cell- and tissue-based therapies. The journal is published by Taylor & Francis and the editor-in-chief is Michael Morse (Duke University Hospital). The journal was established in 2001 and according to the Journal Citation Reports, it has a 2017 impact factor of 3.974.[1] The journal is also indexed in MEDLINE.
References
- ^ "Expert Opinion on Biological Therapy". 2017 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2018.
External links
- Official website
- v
- t
- e
  | This article about a pharmacology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |
- v
- t
- e
